PeerVoice

Independent medical education helping physicians acquire new clinical skills, test their knowledge, and improve their practice of medicine

[PeerVoice @PeerVoice]

Watch Now: https://t.co/UJITN1ob5w
Choices, Risks, and Relief: An Expert Debate on Modern Menopause Management – Learn More in This New CE Activity!
#PeerVoice #MedEd #CE #menopause #perimenopause #womenshealth

[PeerVoice @PeerVoice]

Missed the #PeerVoice #CE symposium in Seoul? Watch it on demand to explore the clinical significance of HER2 mutations and contemporary best practices in managing cases of advanced NSCLC.
https://t.co/UUJhCBSv4W
#meded #oncology #pulmonology #NSCLC #lungcancer #HER2 #WCLC26

[PeerVoice @PeerVoice]

What’s new for IgA nephropathy (IgAN)? Watch a recap from Denver and get your CME credit!
#PeerVoice #meded #nephrology #glomerulardisease #IgAN #kidneydisease
https://t.co/ZDpqOB8dds

[PeerVoice @PeerVoice]

Watch a #CME activity on challenges and emerging approaches in progressive #multiplesclerosis and check out Neuroimmunology Matters at https://t.co/BVzwQfJkSN a site presented by #PeerVoice in collaboration with Prof Wiendl and #ISNI 
#neuroimmunology
https://t.co/fz7N7n5hmh

[PeerVoice @PeerVoice]

It’s happening tonight at #ESMO26!
Join us for our symposium on navigating the changing landscape of #mCRPC management.
📅 October 25
⏰ 18:30 - 20:00 CET
🍴 Complimentary dinner bags provided
📍 Hall 10 - North Entrance - Salamanca room
Learn more at https://t.co/gDRkvCUtgQ

[PeerVoice @PeerVoice]

When Less is More: Taking a Closer Look at Next-Generation Gadolinium-Based Contrast Agents in Contrast-Enhanced MRI. Get expert insights in this new streaming presentation. #PeerVoice #meded #radiology #MRI #CEMRI #GBCAs

https://t.co/EnnzWcd52e

[PeerVoice @PeerVoice]

Check out a new three-part activity on the trials driving innovation in #CKD and hear from experts on what makes eGFR-based endpoints clinically meaningful. 
#PeerVoice #nephrology #chronickidneydisease
https://t.co/SE5POGoE1A

[PeerVoice @PeerVoice]

ESMO time is coming up! The PeerVoice team is pleased to invite you to join our experts in Madrid for our dinner symposium on mCRPC.
Come visit our event website for registration and get the latest information from this event: https://t.co/rVVyYntLX7
#ESMO26 #mCRPC #CME

[PeerVoice @PeerVoice]

Watch Now: https://t.co/pIKUfHTSrI
Where Change Begins: Why and How the Power of Primary Care Can Combat the Disruptive Symptoms of Menopause. Learn More in This New CE activity!
#PeerVoice #MedEd #CE #menopause #perimenopause #womenshealth

[PeerVoice @PeerVoice]

Join us tomorrow in Vienna for our Cutaneous Lupus Erythematosus CE-accredited Symposium at #EADVCongress!
⏱️ 12.30PM CET, meet us at 📍Hall E2 room and take part in this interactive session on #CLE with Drs Min, Wittmann and Figueras-Nart.
Lunch bags provided! #EADVEurope

[PeerVoice @PeerVoice]

Shifting the Status Quo in LS-SCLC: The Practicalities of Integrating Immunotherapy Into Treatment Pathways – Learn More in This New CME activity! @LauraAlderMD
https://t.co/FicmoyBT8U
#PeerVoice #MedEd #CME #oncology #radiationoncology #immunotherapy #SCLC

[PeerVoice @PeerVoice]

Thank you to Zosia Piotrowska, Aaron C. Tan & Jon Zugazagoitia for an outstanding #WCLC2026 symposium on #HER2-mutant #NSCLC and patient-centered care.
Missed it? On-demand coming soon: https://t.co/jBfZeIfI9f
#LungCancer #MedEd #CME #NSCLC

[PeerVoice @PeerVoice]

Tomorrow at #WCLC2026: Join Zosia Piotrowska, Aaron C. Tan, and Jon Zugazagoitia for a case-based discussion on selecting and sequencing therapy for advanced #HER2-mutant #NSCLC.
1:45-2:45 PM KST
Room 103, Grand Ballroom, 1F
https://t.co/jBfZeIfajH
#NSCLC #lungcancer

[PeerVoice @PeerVoice]

Watch Now: https://t.co/am8prXUehf
Hear insights from Dr Eileen O’Reilly on how to overcome patient nihilism that accompanies a diagnosis of advanced #PancreaticCancer and an exciting update on novel treatments under investigation. 
#PeerVoice #Oncology #Gastroenterology #CME

[PeerVoice @PeerVoice]

Stream a new 5-part #CE series of short episodes to hear about how comparative trials are shaping the current and future treatment landscape for #psoriaticarthritis 
#PeerVoice #PsA #dermatology #rheumatology #MedicalEducation

https://t.co/UmYhYrcNT1

[Lorenza Rimassa @LorenzaRimassa]

Please join us for a virtual event on #HER2-directed therapies across #biliarytract, #colorectal, and #gastric cancers on @PeerVoice platform.
#BTC #CCA #GIcancers

@FLordick28391 #EricVanCutsem @HUNIMED @HumanitasMilano

[PeerVoice @PeerVoice]

Going to #WCLC2026 in Seoul? Do not miss the #PeerVoice industry symposium.
Join Zosia Piotrowska, Aaron C. Tan, and Jon Zugazagoitia, for a case-based discussion on selecting and sequencing systemic therapies for advanced #HER2-mutant #NSCLC.
https://t.co/jBfZeIfajH

[PeerVoice @PeerVoice]

Integrating Tumour-Agnostic With Tumour-Specific Treatments for HER2+ GI Cancers: Watch #CE replay to learn about the evolving role of HER2 as actionable biomarker!
https://t.co/WEEDWbm76l
#PeerVoice #meded #oncology #gastroenterology #GIcancers #mCRC #BTC #gastriccancer

[PeerVoice @PeerVoice]

A Case-Based Masterclass Series: From Guidelines to Practice in the Management of #IgAN
#PeerVoice #MedEd #nephrology #CME #IgAN #nephropathy #glomerulardisease
https://t.co/0VQqmDDMgr

[PeerVoice @PeerVoice]

Strategies to Success in #IgAN Management: Harmonizing the Latest Evidence and Guidance to Maximize the Potential of Foundation Treatment Strategies
#PeerVoice #MedEd #nephrology #CME #IgAN #nephropathy #glomerulardisease
https://t.co/3QYHy700tV